Skip to content Menu

RETINA Roundup

Sidebar
  • HOME
  • Subscribe
  • CATEGORIES
    • RETINA
    • Meeting Coverage
    • Clinical Trials
    • Education
    • Vitreoretinal Surgery
    • Clinical Pearls
    • Imaging
    • Coding Corner
  • CONTACT US
  • AUTHORS
  • EDITORS
  • RETINA®
  • RETINAL CASES & BRIEF REPORTS

Category: AMD

Posted on October 1, 2021October 2, 2021

Retina Society 2021 – J. Donald M. Gass Award Presentation, Dr. Bailey Freund

Theodore Bowe, MD Ophthalmology Resident Wills Eye Hospital, Philadelphia PA Dr. K. Bailey Freund, Clinical Professor of Ophthalmology at the NYU Grossman School of Medicine, was awarded the J. Donald…

Continue Reading
Posted on July 17, 2021July 17, 2021

RETINA Article Feature: Pentosan Polysulfate and Vision – Findings from an International Survey of Exposed Individuals

“Pentosan Polysulfate and Vision: Findings from an International Survey of Exposed Individuals” by Uner et al. July 2021 Elizabeth Rossin M.D., Ph.D.Instructor in Ophthalmology, Mass Eye and EarBoston, MA Avni…

Continue Reading
Posted on September 18, 2018September 18, 2018

Retina Society 2018: AMD Session Part II

Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor  We continue coverage of the 2018 Retina Society annual meeting in San Francisco. Yesterday we presented summaries…

Continue Reading
Posted on September 16, 2018September 16, 2018

Retina Society 2018: AMD Part I (Including First-Time Presentation of Genentech’s Bispecific Anti-VEGF/Ang2 Agent for Neovascular AMD)

Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor The age-related macular degeneration (AMD) session at Retina Society is always jam-packed. Patients with AMD comprise a…

Continue Reading
Posted on September 12, 2017September 12, 2017

Not All is Dry with Dry AMD

And now…finally…some good news in dry AMD! Geographic atrophy (GA) remains a significant unmet need that has been met with great attention by investigators and industry. However, until now, all…

Continue Reading
Posted on September 9, 2017September 10, 2017

Lampalizumab Does Not Meet Primary Endpoint

Genentech reported yesterday that lampalizumab did not meet the primary endpoint in SPECTRI, one of the two parallel Phase III clinical trials investigating lampalizumab injections for the treatment of geographic…

Continue Reading
Posted on August 26, 2017August 27, 2017

HAWK/HARRIER: Coming in for a Landing

In June, Novartis announced results from HAWK and HARRIER, two phase III clinical trials comparing brolocizumab (formerly RTH258) to aflibercept for the treatment of wet AMD. The primary endpoints were…

Continue Reading
Posted on August 14, 2017August 15, 2017

ASRS 2017 Monday (Day 4): Neovascular AMD

Day 4 of the ASRS annual meeting has provided us with even more clinically relevant information regarding neovascular age-related macular degeneration (nvAMD) and retinal detachments (RDs). Both Geoffrey Emerson and…

Continue Reading

Posts pagination

Previous Page Page 1 … Page 9 Page 10 Page 11 Next Page
Proudly powered by WordPress | Theme: Perennial by DesignOrbital.
Top

WELCOME

Welcome to Retina Roundup, the official blog of the journals RETINA® and Retinal Cases and Brief Reports.

Our goal is to provide readers an up-to-date forum for information that impacts not only our field but those who might one day find themselves in our care. We hope that you find the articles on this site useful.

Search RETINA Round Up

RETINA®

Click to browse the current issue.

Retinal Cases & Brief Reports

Click to browse the current issue
RETINA Roundup
Proudly powered by WordPress Theme: Perennial.
 

Loading Comments...